Faecal calprotectin in primary care: is its current use supported by the evidence?
- PMID: 39222433
- PMCID: PMC10904130
- DOI: 10.3399/bjgp24X736665
Faecal calprotectin in primary care: is its current use supported by the evidence?
Conflict of interest statement
The authors have declared no competing interests.
Figures
References
-
- Turner D, Ricciuto A, Lewis A, et al. STRIDE-II: an update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) initiative of the International Organization for the Study of IBD (IOIBD): determining therapeutic goals for treat-to-target strategies in IBD. Gastroenterology. 2021;160(5):1570–1583. - PubMed
-
- Conroy S, Hale MF, Cross SS, et al. Unrestricted faecal calprotectin testing performs poorly in the diagnosis of inflammatory bowel disease in patients in primary care. J Clin Pathol. 2018;71(4):316–322. - PubMed
-
- National Institute for Health and Care Excellence (NICE) Faecal calprotectin diagnostic tests for inflammatory diseases of the bowel. DG11. London: NICE; 2013. https://www.nice.org.uk/guidance/dg11 (accessed 6 Feb 2024).
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical